查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2092678

癌症基因組檢測及分析市場：依檢測類型、技術、癌症類型、最終用途、應用、國家及地區分類－產業分析、市場規模、市場佔有率及2026年至2033年預測

Genomic Cancer Panel and Profiling Market, By Testing Type, By Technology, By Cancer Type, By End-Use, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 444 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，癌症基因組檢測和分析市場價值將達到 116.807 億美元，並將在 2026 年至 2033 年以 8.9% 的複合年成長率成長。

基因組癌症檢測和基因分型是用於識別患者腫瘤基因組成的診斷技術。它們分析DNA、RNA和其他遺傳物質，以識別可能導致癌症生長和進展的改變。這些檢測利用先進的定序技術同時評估多個基因，檢測突變、基因融合、拷貝數變異和其他類型的分子變化。所獲得的見解有助於醫療專業人員更深入地了解癌症的獨特特徵，並制定更合適的治療策略。

癌症基因組檢測及分析市場—市場動態

企業對雲端原生應用的需求不斷成長，加上自動化和人工智慧整合技術的進步，預計將推動市場需求。

基因組癌症檢測和分析市場成長的主要促進因素之一是精準腫瘤學的日益普及。癌症治療正從千篇一律的治療方案轉向針對每位患者腫瘤基因組成量身定做的治療方案。基因組分析有助於腫瘤科醫師檢測具有治療意義的突變、基因融合以及其他影響癌症進展和治療的分子生物標記。這使得識別標靶治療和免疫療法成為可能，從而提高治療效果、改善患者預後並避免選擇療效較差的療法。全球癌症負擔的日益加重也是推動市場擴張的重要因素。根據世界衛生組織（WHO）預測，到2050年，全球將新增3,500萬例癌症病例，而且這一數字預計還會持續成長。

隨著癌症發生率的上升，醫療系統越來越依賴先進的診斷工具來支持個人化治療方案的發展。癌症基因組分析有助於醫生更早確定最佳治療策略，最大限度地減少試驗治療決策，並改善臨床試驗的患者篩選。此外，標靶癌症療法和伴隨診斷的日益普及，也提升了基因組檢測的臨床意義，使得全面的分子分析成為現代癌症治療中日益重要的一環。

癌症基因組檢測和分析市場正蓬勃發展，這主要得益於基因測序技術，特別是次世代定序（NGS）技術的不斷進步。近年來，隨著定序速度、準確性和數據分析能力的提升，識別癌症相關基因變異的能力顯著增強。自動化技術的進步也簡化了檢測流程，並提高了結果交付效率。因此，越來越多的醫療機構將基因組分析納入常規癌症診斷和治療方案製定中，進一步推動了市場成長。

癌症基因組檢測及分析市場－市場區隔分析：

全球基因組癌症檢測和分析市場按檢測類型、技術、癌症類型、最終用途、應用領域和地區進行細分。

根據檢測類型，該市場可細分為七類：綜合基因組分析 (CGP)、標靶基因檢測、全基因測序(WGS)、全外EXOME定序(WES)、基於液態生物檢體的基因組分析、基於固態切片檢查的基因組分析以及其他。綜合基因組分析 (CGP) 在基因組癌症檢測市場中佔據較大佔有率，因為它只需一次檢測即可提供腫瘤分子水平的詳細資訊。與僅關注有限數量預定義基因的標靶基因檢測不同，CGP 可同時分析數百個癌症相關基因，從而更全面地了解腫瘤的遺傳組成。這種廣泛的檢測方法能夠識別多種基因組變異，包括基因突變、拷貝數變異和基因重排。

基因組癌症檢測及分析市場—區域分析

北美市場的成長主要得益於精準醫療在常規癌症治療中日益廣泛的應用。領先的癌症研究機構、大學附屬醫院和專科癌症診所正積極利用基因組分析為每位患者制定個人化治療方案。醫療服務提供者、研究機構和相關人員在開發新型基因組檢測方面的合作，正在鞏固該地區精準腫瘤學的基礎，並推動全面基因組分析在臨床實踐中的更廣泛應用。在歐洲，液態生物檢體技術和先進基因組分析解決方案的日益普及，也促進了市場的成長。

醫療機構正擴大利用基於血液的基因組檢測作為傳統組織切片檢查的一種微創替代方案，尤其是在癌症檢測、疾病後續觀察和療效評估方面。同時，人工智慧、機器學習和先進的生物資訊學工具正在改善複雜基因組數據的分析和解讀。這些技術使臨床醫生能夠更快、更準確地獲得訊息，從而支持更明智的治療決策，並促進基因組分析在全部區域的廣泛應用。

目錄

第1章：癌症基因組檢測與分析市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：癌症基因組檢測與分析的關鍵市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：癌症基因組檢測與分析的產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章 癌症基因組檢測與分析市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：癌症基因組檢測與分析的市場趨勢

  • 癌症基因組檢測及分析市佔率分析（2025 年）
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 癌症基因體檢測及分析市場：依檢測類型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按測試類型
    • 綜合基因組分析（CGP）
    • 目標基因面板
    • 全基因測序（WGS）
    • 全EXOME定序（WES）
    • 其他

第8章 癌症基因組檢測與分析市場：依技術分類

  • 概述
    • 基於細分市場的市場佔有率分析：按技術分類
    • 次世代定序（NGS）
    • 聚合酵素鏈鎖反應（PCR）
    • 螢光原位雜合反應（FISH）
    • 微陣列分析
    • 其他

第9章 癌症基因組檢測與分析市場：依癌症類型分類

  • 概述
    • 按癌症類型分類的市場佔有率分析：
    • 乳癌
    • 肺癌
    • 結腸癌
    • 攝護腺癌
    • 骨髓惡性腫瘤
    • 其他

第10章 癌症基因組檢測與分析市場：依最終用途分類

  • 概述
    • 按最終用途分類的市佔率分析。
    • 醫院
    • 臨床診斷檢測實驗室
    • CRO
    • 其他

第11章 癌症基因組檢測與分析市場：依應用領域分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 臨床診斷
    • 生物標記發現
    • 伴隨診斷
    • 藥物發現與開發
    • 出於研究目的
    • 其他

第12章 癌症基因組檢測與分析市場：按地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第13章 主要供應商分析：癌症基因組檢測與分析產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Illumina, Inc.
    • Thermo Fisher Scientific Inc.
    • F. Hoffmann-La Roche Ltd
    • QIAGEN NV
    • Agilent Technologies, Inc.
    • Guardant Health, Inc.
    • Exact Sciences Corporation
    • Foundation Medicine, Inc.
    • Caris Life Sciences
    • Tempus AI, Inc.
    • NeoGenomics Laboratories, Inc.
    • Myriad Genetics, Inc.
    • Natera, Inc.
    • BGI Genomics Co., Ltd.
    • Personalis, Inc.
    • Others

第14章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV6885

Genomic Cancer Panel and Profiling Market size was valued at USD 11,680.7 Million in 2025, expanding to a CAGR of 8.9% from 2026 to 2033.

Genomic cancer panel and profiling is a diagnostic technique to determine the genetic makeup of a patient's tumor. It looks at DNA, RNA and other genetic material to find changes that could be causing the cancer to grow and progress. The test uses advanced sequencing technologies to simultaneously assess multiple genes and is able to detect mutations, gene fusions, copy number variations, and other types of molecular changes. The knowledge gained helps healthcare providers to better understand the unique characteristics of a cancer and make better treatment decisions.

Genomic Cancer Panel and Profiling Market- Market Dynamics

Increasing enterprise demand for cloud-native applications and growing automation, Ai integration are expected to propel market demand

One of the primary factors driving growth in the genomic cancer panel and profiling market is the increasing adoption of precision oncology. Cancer treatment is shifting away from a one-size-fits-all approach toward therapies tailored to the genetic makeup of an individual patient's tumor. Genomic profiling can assist oncologists in detecting actionable mutations, gene fusions and other molecular biomarkers that impact the development and treatment of a cancer. This allows for the identification of targeted therapies and immunotherapies that can increase the effectiveness of treatment and improve patient outcomes and reduce exposure to less effective treatment options. The rising global burden of cancer is also contributing significantly to market expansion. According to the World Health Organization (WHO), 35 million new cancer cases are expected to be diagnosed worldwide by 2050, and the number is expected to continue further.

As cancer incidence grows, healthcare systems are placing greater emphasis on advanced diagnostic tools that support personalized treatment planning. Genomic cancer profiling helps physicians identify the most appropriate therapeutic strategies at an earlier stage, minimizes trial-and-error treatment decisions, and improves patient selection for clinical trials. Furthermore, the growing availability of targeted oncology drugs and companion diagnostics has increased the clinical relevance of genomic testing, making comprehensive molecular profiling an increasingly important component of modern cancer care.

The genomic cancer panel and profiling market is growing with the help of constant improvements in genomic sequencing technologies, especially next-generation sequencing (NGS). The ability to identify genetic changes that are related to cancer has improved greatly over the years with improvements in sequencing speed, accuracy, and data analysis. Automation has also been increased, making the testing processes more streamlined, and the results can be delivered more efficiently. As a result, more and more healthcare providers are integrating genomic profiling into the routine diagnosis and treatment planning for cancer, which is fueling the market growth.

Genomic Cancer Panel and Profiling Market- Segmentation Analysis:

The Global Genomic Cancer Panel and Profiling Market is segmented on the basis of Testing Type, Technology, Cancer Type, End-Use, Application, and Region.

The market is divided into seven categories based on Testing Type: Comprehensive Genomic Profiling (CGP), Targeted Gene Panels, Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), liquid biopsy-based genomic profiling, solid biopsy-based genomic profiling, and others. Comprehensive Genomic Profiling (CGP) holds the substantial share of the genomic cancer panel and profiling market because it provides a detailed molecular understanding of tumors through a single test. Unlike targeted gene panels, which focus on a limited number of predefined genes, CGP analyzes hundreds of cancer-related genes simultaneously, offering a more comprehensive view of a tumor's genetic makeup. This broader approach helps identify a wide range of genomic alterations, including gene mutations, copy number changes, gene rearrangements, etc.

Genomic Cancer Panel and Profiling Market- Geographical Insights

North America's market growth is being strongly supported by the increasing integration of precision medicine into routine cancer care. Leading cancer research institutions, academic medical centers, and specialized oncology clinics are making greater use of genomic profiling to tailor treatment plans to individual patients. Through collaboration between healthcare providers, research organizations and industry stakeholders to develop new genomic testing, the region's precision oncology landscape has been strengthened, driving wider adoption of comprehensive genomic profiling into clinical practice. In Europe, the market is growing because of the increasing use of liquid biopsy technologies and advanced genomic analysis solutions.

Healthcare providers are increasingly turning to blood-based genomic testing as a less invasive alternative to conventional tissue biopsies, particularly for cancer detection, disease monitoring, and evaluating treatment effectiveness. At the same time, artificial intelligence, machine learning, and advanced bioinformatics tools are improving the analysis and interpretation of complex genomic data. These technologies enable clinicians to generate faster and more accurate insights, supporting better-informed treatment decisions and contributing to the growing adoption of genomic profiling across the region.

United States Genomic Cancer Panel and Profiling Market- Key Insights

The United States is the prominent market for genomic cancer panels and profiling, supported by its strong emphasis on precision medicine, well-established healthcare infrastructure, and widespread use of molecular diagnostics in cancer care. As oncology increasingly moves toward biomarker-driven treatment approaches, healthcare providers are making genomic testing a routine part of clinical decision-making. The growing cancer burden is also contributing to demand for advanced diagnostic solutions. According to the American Cancer Society, more than 2 million new cancer cases are expected to be diagnosed annually in the United States, underscoring the need for technologies that can help deliver more personalized and effective treatment strategies. In addition, the rising number of FDA-approved targeted cancer therapies is further increasing the importance of genomic profiling, as these tests help identify patients who are most likely to benefit from specific treatments.

Genomic Cancer Panel and Profiling Market- Competitive Landscape:

The genomic cancer panel and profiling market is highly competitive, with diagnostic companies, sequencing technology providers, biotechnology firms, and specialized molecular testing laboratories all striving to strengthen their presence in the growing precision oncology space. As demand for personalized cancer care continues to rise, companies are investing heavily in expanding their testing portfolios, improving sequencing performance, and advancing bioinformatics tools that can deliver deeper and more clinically meaningful insights into tumor genetics.

A major area of focus is the development of more comprehensive genomic profiling solutions that help clinicians identify actionable mutations and select the most appropriate treatment options for patients. To support this goal, many diagnostic companies are collaborating with pharmaceutical and biotechnology firms to develop companion diagnostics that can determine which patients are most likely to benefit from specific targeted therapies or immunotherapies.

Recent Developments:

In April 2025, Guardant Health announced a long-term partnership with Pfizer aimed at advancing the development and commercialization of precision oncology treatments through its Infinity liquid biopsy platform. The collaboration leverages blood-based genomic testing and circulating tumor DNA (ctDNA) technologies to support biomarker identification.

In May 2025, Illumina strengthened its presence in precision oncology by broadening the availability of its TruSight Oncology Comprehensive assay and enhancing reimbursement support for comprehensive genomic profiling services.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET KEY PLAYERS

  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • Guardant Health, Inc.
  • Exact Sciences Corporation
  • Foundation Medicine, Inc.
  • Caris Life Sciences
  • Tempus AI, Inc.
  • NeoGenomics Laboratories, Inc.
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • BGI Genomics Co., Ltd.
  • Personalis, Inc.
  • Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY TESTING TYPE- MARKET ANALYSIS, 2020-2033

  • Comprehensive Genomic Profiling (CGP)
  • Targeted Gene Panels
  • Whole Genome Sequencing (WGS)
  • Whole Exome Sequencing (WES)
  • Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020-2033

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Fluorescence in Situ Hybridization (FISH)
  • Microarray Analysis
  • Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY CANCER TYPE- MARKET ANALYSIS, 2020-2033

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Hematological Malignancies
  • Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY END-USE- MARKET ANALYSIS, 2020-2033

  • Hospitals
  • Clinical Diagnostic Laboratories
  • CROs
  • Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020-2033

  • Clinical Diagnostics
  • Biomarker Discovery
  • Companion Diagnostics
  • Drug Discovery & Development
  • Research Applications
  • Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY REGION- MARKET ANALYSIS, 2020-2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Genomic Cancer Panel and Profiling Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Genomic Cancer Panel and Profiling Market Snippet by Testing Type
    • 2.1.2. Genomic Cancer Panel and Profiling Market Snippet by Technology
    • 2.1.3. Genomic Cancer Panel and Profiling Market Snippet by Cancer Type
    • 2.1.4. Genomic Cancer Panel and Profiling Market Snippet by End-Use
    • 2.1.5. Genomic Cancer Panel and Profiling Market Snippet by Application
    • 2.1.6. Genomic Cancer Panel and Profiling Market Snippet by Country
    • 2.1.7. Genomic Cancer Panel and Profiling Market Snippet by Region
  • 2.2. Competitive Insights

3. Genomic Cancer Panel and Profiling Key Market Trends

  • 3.1. Genomic Cancer Panel and Profiling Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Genomic Cancer Panel and Profiling Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Genomic Cancer Panel and Profiling Market Opportunities
  • 3.4. Genomic Cancer Panel and Profiling Market Future Trends

4. Genomic Cancer Panel and Profiling Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Genomic Cancer Panel and Profiling Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Genomic Cancer Panel and Profiling Market Landscape

  • 6.1. Genomic Cancer Panel and Profiling Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Genomic Cancer Panel and Profiling Market - By Testing Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Testing Type, 2025 & 2033 (%)
    • 7.1.2. Comprehensive Genomic Profiling (CGP)
    • 7.1.3. Targeted Gene Panels
    • 7.1.4. Whole Genome Sequencing (WGS)
    • 7.1.5. Whole Exome Sequencing (WES)
    • 7.1.6. Others

8. Genomic Cancer Panel and Profiling Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
    • 8.1.2. Next-Generation Sequencing (NGS)
    • 8.1.3. Polymerase Chain Reaction (PCR)
    • 8.1.4. Fluorescence in Situ Hybridization (FISH)
    • 8.1.5. Microarray Analysis
    • 8.1.6. Others

9. Genomic Cancer Panel and Profiling Market - By Cancer Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Cancer Type, 2025 & 2033 (%)
    • 9.1.2. Breast Cancer
    • 9.1.3. Lung Cancer
    • 9.1.4. Colorectal Cancer
    • 9.1.5. Prostate Cancer
    • 9.1.6. Hematological Malignancies
    • 9.1.7. Others

10. Genomic Cancer Panel and Profiling Market - By End-Use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-Use, 2025 & 2033 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Clinical Diagnostic Laboratories
    • 10.1.4. CROs
    • 10.1.5. Others

11. Genomic Cancer Panel and Profiling Market - By Application

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 11.1.2. Clinical Diagnostics
    • 11.1.3. Biomarker Discovery
    • 11.1.4. Companion Diagnostics
    • 11.1.5. Drug Discovery & Development
    • 11.1.6. Research Applications
    • 11.1.7. Others

12. Genomic Cancer Panel and Profiling Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Genomic Cancer Panel and Profiling Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Genomic Cancer Panel and Profiling Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.18. Denmark
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.18.3. Denmark Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.3.18.4. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.18.5. Denmark Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.3.18.6. Denmark Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.3.18.7. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.19. Rest of Europe
      • 12.3.19.1. Overview
      • 12.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.19.3. Rest of the Europe Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.3.19.4. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.19.5. Rest of the Europe Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.3.19.6. Rest of the Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.3.19.7. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Genomic Cancer Panel and Profiling Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.17. Taiwan
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.17.3. Taiwan Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.4.17.4. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.17.5. Taiwan Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.4.17.6. Taiwan Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.4.17.7. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.18. Vietnam
      • 12.4.18.1. Overview
      • 12.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.18.3. Vietnam Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.4.18.4. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.18.5. Vietnam Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.4.18.6. Vietnam Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.4.18.7. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.19. Rest of APAC
      • 12.4.19.1. Overview
      • 12.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.19.3. Rest of APAC Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.4.19.4. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.19.5. Rest of APAC Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.4.19.6. Rest of APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.4.19.7. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Genomic Cancer Panel and Profiling Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Genomic Cancer Panel and Profiling Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.15. Iran
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.15.3. Iran Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.6.15.4. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.15.5. Iran Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.6.15.6. Iran Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.6.15.7. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.16. Qatar
      • 12.6.16.1. Overview
      • 12.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.16.3. Qatar Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.6.16.4. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.16.5. Qatar Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.6.16.6. Qatar Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.6.16.7. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.17. Rest of MEA
      • 12.6.17.1. Overview
      • 12.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.17.3. Rest of MEA Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
      • 12.6.17.4. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.17.5. Rest of MEA Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 12.6.17.6. Rest of MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
      • 12.6.17.7. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)

13. Key Vendor Analysis- Genomic Cancer Panel and Profiling Industry

  • 13.1. Competitive Benchmarking
    • 13.1.1. Competitive Dashboard
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Illumina, Inc.
    • 13.2.2. Thermo Fisher Scientific Inc.
    • 13.2.3. F. Hoffmann-La Roche Ltd
    • 13.2.4. QIAGEN N.V.
    • 13.2.5. Agilent Technologies, Inc.
    • 13.2.6. Guardant Health, Inc.
    • 13.2.7. Exact Sciences Corporation
    • 13.2.8. Foundation Medicine, Inc.
    • 13.2.9. Caris Life Sciences
    • 13.2.10. Tempus AI, Inc.
    • 13.2.11. NeoGenomics Laboratories, Inc.
    • 13.2.12. Myriad Genetics, Inc.
    • 13.2.13. Natera, Inc.
    • 13.2.14. BGI Genomics Co., Ltd.
    • 13.2.15. Personalis, Inc.
    • 13.2.16. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us